NasdaqGS:MRNABiotechs
Is Moderna (MRNA) Pricing Reflect Its mRNA Pipeline Potential After 62% Year To Date Rally
If you are wondering whether Moderna's current share price still reflects its long term potential, you are not alone. This article focuses squarely on what the stock might be worth based on different valuation lenses.
Moderna's share price closed at US$49.87, with returns of 18.1% over the last 7 days, 2.4% over 30 days and 61.6% year to date, while the 1 year return is 40.4% and the 3 and 5 year returns are negative at 64.2% and 67.8% respectively.
Recent headlines have continued to focus...